Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

ABVE vs JBSS: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

JBSS Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 10–0 Matrix Metrics)

JBSS Overall Winner 6-Pillar Tally: ABVE 1 – 5 JBSS Matrix Metrics: ABVE 0 – 10 JBSS

As of Nov 16, 2026, John B. Sanfilippo & SON (JBSS) is the stronger overall head-to-head candidate over Above Food Ingredients Inc. (ABVE) in the Tradestie Institutional Equity Comparison Engine, winning 10–0 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ABVE carries a Unified Composite Score of 39.8/100 (SELL) at $0.11 (N/M Forward P/E, -23.2% operating margin), whereas JBSS carries 43.2/100 (HOLD) at $60.11 (9.8x Forward P/E, 6.7% operating margin).

  • Technical & Structure Timing Caution: ABVE is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.0); meanwhile JBSS is in a Breakdown options structure phase (RSI 49.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About ABVE vs JBSS
ABVE NASDAQ
Above Food Ingredients Inc. Common Stock
Food And Kindred Products
$0.11
-80.57% 1D
Market Cap $30.0M
TTM Revenue $295M
Forward P/E N/M
Beta / 30D Vol 4.10β · 310% Vol
Unified Composite Score
39.8 / 100 SELL
Tech 40.0 Fund 47.0 Flow 57.0 Mom 40.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -29.1%), weak momentum, RSI 28
RSI-14: 28.0 · SMA20: $0.55 · SMA50: $0.67
JBSS NASDAQ Head-to-Head Winner
John B. Sanfilippo & SON
Sugar & Confectionery Products
$60.11
+1.78% 1D
Market Cap $657.4M
TTM Revenue $1.17B
Forward P/E 9.8x
Beta / 30D Vol 0.22β · 65% Vol
Unified Composite Score
43.2 / 100 HOLD
Tech 51.0 Fund 56.0 Flow 59.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 49
RSI-14: 49.3 · SMA20: $59.72 · SMA50: $64.58

6-Pillar Scorecard Institutional Category Breakdown (ABVE 1 – 5 JBSS)

Columns: Metric · ABVE · JBSS
1. Valuation Multiples JBSS
Forward P/E N/M 9.8x
Trailing P/E N/M 11.8x
PEG Ratio N/M 1.52x
EV / Revenue 0.1x 0.7x
2. Growth & Scale JBSS
Revenue Growth (YoY) -45.0% -3.5%
Earnings Growth (YoY) +0.0% -30.2%
TTM Revenue (USD) $295M $1.17B
Market Cap $30.0M $657.4M
3. Profitability & Quality JBSS
Gross Margin -2.8% 17.7%
Operating Margin -23.2% 6.7%
Net Profit Margin -23.4% 4.8%
Return on Equity (ROE) 0.0% 15.4%
4. Balance Sheet & Cash Flow JBSS
Cash Generation (TTM) -$40M EBITDA $30M
Cash Flow Margin -13.7% EBITDA Mgn 2.6%
Net Cash / Leverage 0.0% ROE $140M Net Debt (0.38x D/E)
Dividend Yield None (0.00%) 1.67%
5. Options & Positioning JBSS
Options Structure Phase UNCLASSIFIED BREAKDOWN
Current IV / %ile 148.3% (8th %ile) 19.8% (<1st %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown ACCUMULATION · Neutral
6. R&D & Supply-Chain Moat ABVE
OpEx & R&D Intensity 20.4% of Rev ($60M) 11.0% of Rev ($128M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Packaged Foods Operator Packaged Foods Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: ABVE (0) vs JBSS (10)
Institutional Metric ABVE JBSS Criterion Row Edge
Market Capitalization
Scale
$30.0M $657.4M Larger Scale JBSS
Trailing P/E Ratio
Valuation
N/M 11.8x Lower Multiple JBSS
Forward P/E Ratio
Valuation
N/M 9.8x Lower Multiple JBSS
Revenue Growth (YoY)
Growth
-45.0% -3.5% Higher Growth JBSS
Operating Margin (TTM)
Profitability
-23.2% 6.7% Higher Margin JBSS
Net Profit Margin
Profitability
-23.4% 4.8% Higher Margin JBSS
Return on Equity (ROE)
Capital Efficiency
0.0% 15.4% Higher ROE JBSS
52-Week Range Position
Momentum
0% ($0–$7) 23% ($51–$92) Stronger Trend JBSS
Beta / 30D Volatility
Risk Regime
4.10β · 310% Vol 0.22β · 65% Vol Lower Realized Risk JBSS
Unified Institutional Score
Composite Signal
39.8 / 100 (SELL) 43.2 / 100 (HOLD) Higher Composite JBSS
Trailing 12M Revenue (USD)
Operating Scale
$295M $1.17B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
-2.8% 17.7% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 0.1x EV/Rev 1.52x PEG · 0.7x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$40M EBITDA (0.0% ROE) $30M ($140M Net Debt (0.38x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon JBSS +69.47 pp
ABVE: -79.18% · JBSS: -9.71%
3M Horizon JBSS +80.6 pp
ABVE: -91.43% · JBSS: -10.83%
6M Horizon JBSS +97.48 pp
ABVE: -95.67% · JBSS: +1.81%
1Y Horizon JBSS +103.22 pp
ABVE: -94.38% · JBSS: +8.84%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ABVE vs JBSS. Trailing 12-month operating profitability (ABVE -23.2% vs JBSS 6.7%) and valuation multiples (ABVE N/M vs JBSS 9.8x Forward P/E) are benchmarked directly in Pillar 4 below.

ABVE ADR TTM Benchmark FX-Normalized USD
TTM Revenue$295M
Gross Margin-2.8%
Op. Margin-23.2%
ROE / Fwd P/E0.0% · N/M
JBSS ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.17B
Gross Margin17.7%
Op. Margin6.7%
ROE / Fwd P/E15.4% · 9.8x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
ABVE UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 148.3%
IV Percentile 8th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact ABVE Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
JBSS BREAKDOWN
95d in phase · OBV ACCUMULATION
Current IV 19.8%
IV Percentile <1st %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow ACCUMULATION
Exact JBSS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
ABVE Moat Profile Cyclical / Execution-Driven Positioning
Packaged Foods Operator
Competes within the Packaged Foods value chain with $30.0M market capitalization and -23.2% operating margin.
OpEx & R&D Reinvestment 20.4% of Rev ($60M)
90D Engineering Disclosures 0 Published
JBSS Moat Profile Cyclical / Execution-Driven Positioning
Packaged Foods Operator
Competes within the Packaged Foods value chain with $657.4M market capitalization and 6.7% operating margin.
OpEx & R&D Reinvestment 11.0% of Rev ($128M)
90D Engineering Disclosures 0 Published

Investor FAQ ABVE vs JBSS Key Questions & Quantitative Answers

As of Nov 16, 2026, John B. Sanfilippo & SON (JBSS) is the stronger overall head-to-head candidate over Above Food Ingredients Inc. (ABVE) in the Tradestie Institutional Equity Comparison Engine, winning 10–0 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ABVE carries a Unified Composite Score of 39.8/100 (SELL) at $0.11 (N/M Forward P/E, -23.2% operating margin), whereas JBSS carries 43.2/100 (HOLD) at $60.11 (9.8x Forward P/E, 6.7% operating margin). Technical & Structure Timing Caution: ABVE is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.0); meanwhile JBSS is in a Breakdown options structure phase (RSI 49.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

JBSS leads the Growth & Scale pillar: ABVE posts -45.0% YoY revenue growth and +0.0% YoY earnings growth on $295M TTM revenue (-2.8% gross margin, -23.2% operating margin), compared with JBSS at -3.5% YoY revenue growth and -30.2% YoY earnings growth on $1.17B TTM revenue (17.7% gross margin, 6.7% operating margin). On trailing 12-month operating scale, ABVE generates $295M in USD-normalized revenue versus $1.17B for JBSS. In operating R&D and SG&A reinvestment, ABVE deploys 20.4% of Rev ($60M) (0 90-day corporate R&D disclosures) versus 11.0% of Rev ($128M) (0 disclosures) for JBSS.

JBSS screens cheaper on headline valuation multiples. ABVE trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-13.7% EBITDA margin), whereas JBSS trades at 9.8x Forward P/E, 11.8x Trailing P/E, 1.52x PEG, and 0.7x EV/Revenue (2.6% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ABVE (0.0% ROE) versus JBSS (15.4% ROE) capital efficiency.

In options market volatility and institutional positioning, ABVE carries 148.3% implied volatility (8th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (4.10β · 310% Vol realized risk). By comparison, JBSS carries 19.8% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (0.22β · 65% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.